PRIORIX Trademark

Trademark Overview

On Friday, February 4, 2022, a trademark application was filed for PRIORIX with the United States Patent and Trademark Office. The USPTO has given the PRIORIX trademark a serial number of 97254008. The federal status of this trademark filing is REGISTERED as of Tuesday, July 2, 2024. This trademark is owned by GlaxoSmithKline Biologicals SA. The PRIORIX trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines
priorix

General Information

Serial Number97254008
Word MarkPRIORIX
Filing DateFriday, February 4, 2022
Status700 - REGISTERED
Status DateTuesday, July 2, 2024
Registration Number7431303
Registration DateTuesday, July 2, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 16, 2024

Trademark Statements

Goods and ServicesVaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 9, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxoSmithKline Biologicals SA
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE
Party NameGlaxoSmithKline Biologicals SA
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE
Party NameGlaxoSmithKline Biologicals SA
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Trademark Events

Event DateEvent Description
Tuesday, February 8, 2022NEW APPLICATION ENTERED
Wednesday, June 29, 2022ASSIGNED TO EXAMINER
Monday, July 11, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, February 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 8, 2022NON-FINAL ACTION WRITTEN
Friday, July 8, 2022NON-FINAL ACTION E-MAILED
Friday, July 8, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 11, 2022SUSPENSION LETTER WRITTEN
Monday, July 11, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, August 3, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, August 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, March 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, January 28, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, August 12, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, August 24, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, February 26, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, March 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

priorix vaccines